EDCTP3Global Health EDCTP3 Advances Research on HIV, Malaria, and Neglected Diseases
New Projects target HIV and malaria among other diseases
The 2024 Global Health European & Developing Countries Clinical Trials Partnership 3 (Global Health EDCTP3) calls have resulted in the selection of 29 projects with research and innovation spanning areas such as HIV, malaria, neglected infectious diseases, and digital health, these initiatives aim to deliver tangible impact where it is needed most. The newly signed projects represent an investment of €161 million, complemented by an additional €29 million committed to projects currently under grant preparation.
104 project proposals received for 2025 Global Health EDCTP3 calls
Global Health EDCTP3 has received 104 applications by the 3 September second-stage deadline for the 2025 calls. Applicants have requested nearly €666.5 million in Global Health EDCTP3 funding, against the indicative call budget of €239.8 million.
The 2025 Global Health EDCTP3 calls invited applicants to submit applications across seven different topics for the largest and most ambitious work programme since the creation of the Joint Undertaking in 2021.
EDCTP3 supports global clinical trial strengthening
Global Health EDCTP3 joined other leading research funders in endorsing the joint statement on strengthening clinical trials 2025. The statement reinforces the WHO Guidance for Best Practices for Clinical Trials as the international benchmark for the design and reporting of high-impact studies and is a collective effort intended to improve the quality, transparency and relevance of clinical trials around the world by promoting best practices and sustainable national infrastructure.
EDCTP3 participates in the 14th ECTMIH
The EDCTP3 presented at the 14th European Congress on Tropical Medicine and International Health, which took place from 29th September, 2025 to 2nd October, 2025 in Hamburg, Germany. Executive Director of Global Health EDCTP3 Dr Michael Makanga gave the keynote lecture on digital innovations, behavioural research and implementation at the plenary session titled, ‘Better Health’.
